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This study aimed to assess and compare eﬀectiveness of Autoﬂuorescence imaging (AFI) in diagnosis of early gastric cancer
(EGC) between experienced and less experienced endoscopists. Fifty selected images (20 neoplastic lesions and 30 benign
lesions/areas)ofbothwhitelightendoscopy(WLE)andAFIwereblindlyreviewedbytwogroups;ﬁrstconsistedofﬁveexperienced
endoscopists and second included ﬁve less experienced endoscopists. Sensitivity, speciﬁcity, and accuracy were 70%, 78%, and
75%, respectively, for AFI and 81%, 76%, and 78%, respectively, for WLE in the experienced group. In the less experienced group,
sensitivity, speciﬁcity and accuracy were 80%, 81% and 80%, respectively, for AFI and 65%, 77%, and 72%, respectively, for WLE.
Interobserver variability for the less experienced group was better with AFI than WLE. AFI improved sensitivity of endoscopic
diagnosis of neoplastic lesions by less experienced endoscopists, and its use could beneﬁcially enhance the clinical eﬀectiveness of
EGC screening.
1.Introduction
Gastric cancer incidence and mortality have declined dra-
matically over the past 70 years [1]. Despite these declines,
gastric cancer is still the fourth most common cancer and
the second leading cause of cancer-related deaths worldwide
[2]. Development of esophagogastroduodenoscopy (EGD),
a screening tool for early gastric cancer (EGC), in place of
radiology[3]hasallowedwidespreadavailabilityofscreening
in high-risk countries such as Japan and Korea resulting in
decreasedmortality.Incontrast,relativelyfewgastriccancers
arediscoveredatanearlystageinmostWesterncountries[4].
We have witnessed ﬁrsthand signiﬁcant advances in en-
doscopic treatment for early gastric cancer in recent years
including development of endoscopic submucosal dissection
(ESD) [5–7]. In order to fully beneﬁt from the advantages
of endoscopic treatment, however, it is important to detect
gastric cancers at the earliest possible stage [8]. Most cases
of EGC are slightly depressed or elevated lesions and red
or pale in color, but some EGC are quite ﬂat and almost
isochromatic so there is very little contrast with the sur-
rounding mucosa. Such subtle changes of EGC can make for
a challenging endoscopic diagnosis. The diﬃculties involved
in making an accurate diagnosis can be compounded by the
inexperience of some endoscopists particularly in countries
where the incidence of gastric cancer is low.
Following development of a ﬂuorescence detection
method for neoplastic lesions in 1957, autoﬂuorescence
imaging (AFI) has attracted considerable attention in the
diagnosis of early cancerous lesions [9, 10] .A F Ii sa
novel imaging method that produces computerized real-
time pseudocolor images by detecting faint ﬂuorescence2 Diagnostic and Therapeutic Endoscopy
Table 1: Neoplastic lesion characteristics and AFI colors.
Number of lesions AFI color
Magenta Green
Pathological type
Carcinoma (diﬀerentiated) 13 9 4
Carcinoma (undiﬀerentiated) 3 0 3
Adenoma 4 4 0
Location
Upper third of stomach 2 1 1
Middle third of stomach 9 6 3
Lower Third of Stomach 9 6 3
Macroscopic type
Elevated 9 9 0
Flat 2 2 0
Depressed 9 2 7
WLE color
Reddish 9 4 5
Isochromatic 8 8 0
Pale 3 1 2
AFI: autoﬂuorescence imaging; WLE: white light endoscopy.
emittedfromendogenousﬂuorophoresexposedtoexcitation
light. Neoplastic lesions with an altered ﬂuorescence can
be distinguished from the enhanced surrounding normal
pattern by variations in color.
Several published reports have examined the advantages
of AFI for detection of colorectal cancer [11–14]. It may also
be easier for less experienced endoscopists to detect gastric
neoplastic lesions using AFI even when such lesions cannot
be detected by conventional white light endoscopy (WLE)
[15]. The aim of this pilot study was to assess and then
compare the eﬀectiveness of AFI in the diagnosis of gastric
neoplastic lesions between experienced and less experienced
endoscopists.
2. Methods
2.1. Study Design. During endoscopy using a prototype AFI
system that included both WLE and AFI functions per-
formed by one experienced endoscopist (C. Yokoi), pictures
of neoplastic lesions and benign lesions/areas were taken
from 44 patients with EGC after obtaining their informed
consent who were referred to our hospital for treatment
from August 2005 to March 2006. Pictures of 45 EGCs were
collected along with 172 pictures of benign lesions/areas
from these 44 patients. All neoplastic and benign lesions
were assessed histopathologically from biopsy specimens.
Pictures of poor quality were excluded, and 50 pictures
were then selected at random by the study coordinator
(K. Tada) for this pilot study including 20 pictures of
neoplastic lesions (four adenomas and 16 EGCs) and 30
pictures of benign lesions/areas (four polyps, six ulcer scars,
four atrophic changes, and 16 normal mucosal areas). The
clinicopathological characteristics of the neoplastic lesions
wereclassiﬁed based on the Japanese Classiﬁcation of Gastric
Carcinoma [16] while the descriptions of WLE and AFI
colors were determined by the study coordinator (Table 1).
All slightly elevated and ﬂat lesions appeared magenta in a
green ﬁeld, and 7 of 9 slightly depressed lesions displayed
green in a magenta ﬁeld. The mean lesion size was 20mm.
We prepared 50 sets of AFI and WLE images for the
same selected lesions and normal mucosa. Each image was
assigned a random sequence number with the 50 AFI images
displayed ﬁrst followed by the 50 WLE images. A review of
the images was performed individually by 10 endoscopists
excludingtheendoscopistwhotooktheimagesandthestudy
coordinator who were divided into two separate groups:
ﬁve endoscopists with extensive experience in EGC from
the National Cancer Center Hospital (NCCH) and ﬁve less
experienced endoscopists working in a general hospital. Each
of the endoscopists in the ﬁrst group of reviewers had over
10 years of medical experience including more than three
years at NCCH and had evaluated in excess of 700 EGCs
annually. The endoscopists in the second group of reviewers
each had less than ﬁve years of medical experience and
had evaluated fewer than 30 cases of EGC per year. No
information regarding any of the lesions was available to the
reviewers. An answer sheet was given to each endoscopist
with two options regarding each image: “neoplasm exists” or
“no neoplasm.”
2.2. Autoﬂuorescence Imaging System. The prototype AFI
system used in this study (XGIF-Q240FZ; Olympus Medical
Systems Corp., Tokyo, Japan) was equipped with two charge-
coupled devices (CCDs) at the tip of the endoscope that
could easily be switched by pushing a single button on the
scope handle: one for high-resolution white-light observa-
tion and the other for autoﬂuorescence observation. The AFI
system digitally creates real-time pseudocolor images from
autoﬂuorescence (excitation at 390–470nm and detection at
500–630nm) and green reﬂection (G ) at 540–560nm. The
systemreliesonasequentialmethodinordertoprovideclear
image proﬁles and distinguish autoﬂuorescence reduction of
neoplastic lesions caused by hemoglobin absorption.
2.3. AFI Diagnostic Criteria for Neoplastic Lesions. An e o -
plastic lesion was deﬁned for AFI purposes as an area that
contrasts in color with the surrounding background such asDiagnostic and Therapeutic Endoscopy 3
(a) (b)
Figure 1: Diagnostic criteria for autoﬂuorescence imaging (AFI). We deﬁned a lesion suspected of being neoplasia using AFI (AFI-positive)
as an area that was clearly diﬀerent from the surrounding mucosa in color. (a) WLE image of an EGC. (b) AFI-positive image displayed the
same EGC as a magenta area with deﬁned margins within the green-colored mucosa.
Table 2: Interobserver variability for detection of neoplastic lesions













AFI: autoﬂuorescence imaging; WLE: white light endoscopy.
“amagentaareainagreenﬁeld”or“agreenareainamagenta
ﬁeld” (Figure 1).
AFI images are considerably diﬀerent from those of
conventional WLE, however, so endoscopists have to become
familiar with such images in order to attain an appropriate
level of diagnostic skill. All participating endoscopists in this
study were briefed on how to evaluate AFI images and given
an opportunity to review 10 sample pictures beforehand at a
30-minute training lecture.
2.4. Statistical Analysis. We compiled the answers for the ﬁve
endoscopists in each group and then calculated sensitivity,
speciﬁcity, and accuracy for both groups. Data were analyzed
using the chi-square test, and value diﬀerences of P<
0.05 were considered statistically signiﬁcant. Interobserver
variability was determined for each group using Kappa (κ)
statistics.AllstatisticalanalyseswereperformedusingSTATA
version 10.0 (StataCorp, College Station, Tex, USA).
3. Results
Detection of neoplastic lesions by the experienced endo-
scopists using AFI and WLE, respectively, resulted in a
sensitivity of 70% (95% CI 60–78%) and 81% (95% CI
72–88%), a speciﬁcity of 78% (95% CI 71–84%) and 76%
(95% CI 69–82%), and an accuracy of 75% and 78%. Less
experienced endoscopists had a sensitivity of 80% (95% CI
71–87%) and 65% (95% CI 55–74%), a speciﬁcity of 81%
(95% CI 74–86%) and 77% (95% CI 70–83%), and an
accuracy of 80% and 72%, respectively, using AFI and WLE
for diagnosis. Sensitivity in the less experienced group of
endoscopists using AFI (80%) was signiﬁcantly higher than
when using WLE (65%) (P<0.05). And sensitivity in the
less experienced group of endoscopists using AFI (80%) was
comparable to the more experienced group of endoscopists
using WLE (81%) (Figure 4).
Interobserver variability for detection of neoplastic
lesions by the group of less experienced endoscopists was
better for AFI than with WLE (experienced group: AFI [κ =
0.42 (95% CI 0.33–0.51)] and WLE [κ = 0.52 (95% CI 0.43–
0.61)]; less experienced group: AFI [κ = 0.52 (95% CI 0.43–
0.61)] and WLE [κ = 0.29 (95% CI 0.20–0.38)]). There
was no statistically signiﬁcant diﬀerence in the interobserver
variability using AFI between the experienced and less
experienced endoscopist groups. In contrast, there was a
signiﬁcant diﬀerence using WLE between the two groups
with the experienced endoscopist group having signiﬁcantly
better interobserver variability (Table 2).
With regard to lesions diagnosed by the group of less
experienced endoscopists, three of the 20 (15%) neoplastic
lesions were diagnosed more often by WLE, and 11 (55%)
were diagnosed more often by AFI. All three (100%) neo-
plasias diagnosed more often by WLE were slightly depressed
lesions.(Figures2(a),2(b),and2(c)).Incontrast,eightofthe
11 (73%) neoplasias diagnosed more often by AFI were ﬂat
lesions (Figures 3(a) and 3(b)).
4. Discussion
The eﬀectiveness of AFI for diagnosing EGC by highly expe-




Figure 2: These three neoplastic lesions were diagnosed more easily using WLE. All three appeared reddish in color with a slightly depressed
area.
there are no published reports evaluating less experienced
endoscopists [15, 17].
AFI can diﬀerentiate tissue types based on variations
in their ﬂuorescence emissions. When tissue is exposed
to short wavelength (390–470nm) light, endogenous bio-
logical substances such as collagen, nicotinamide adenine
dinucleotide, ﬂavin, and porphyrins are excited leading to
the emission of longer wavelength (500–630nm) ﬂuorescent
light (autoﬂuorescence) [18]. Neoplastic and nonneoplas-
tic tissues have diﬀerent autoﬂuorescence characteristics
includingnuclear-cytoplasmicratio,mucosallayerthickness,
a n dv o l u m eo fb l o o dﬂ o w[ 19]. These characteristics may
facilitate diﬀerentiating between the two. During endoscopy
using the AFI mode, neoplastic lesions contrast with normal
mucosal tissue (i.e., “a magenta area in a green ﬁeld” or “a
g r e e na r e ai nam a g e n t aﬁ e l d ” ) .Diagnostic and Therapeutic Endoscopy 5
(a)
(b)







































Figure 4: AFI and WLE image review results.6 Diagnostic and Therapeutic Endoscopy
AnumberofstudieshavereportedthatAFIiseﬀectivefor
colorectal cancer screening, but this is still debatable while
its suitability for gastric cancer screening remains somewhat
more controversial [11–14, 20, 21]. Inﬂammatory and
hyperplastic changes in the stomach can alter mucosal layer
thickness and blood ﬂow volume causing autoﬂuorescence
contrast variations with similar appearance to neoplastic
lesions.SuchdiﬃcultiesarealsoreportedinBarrett’sesopha-
gus [22]. False-positive results and low speciﬁcity, therefore,
are more common in the stomach and Barrett’s esophagus.
Currently, AFI cannot distinguish precisely between gastric
neoplasticlesionsandinﬂammatoryorhyperplasticchanges.
It is already known, however, that EGC is not easily detected
by less experienced endoscopists. No detection, of course,
meansthereisnotreatment,soourprimaryobjectiveinEGC
screening should be higher sensitivity rather than diagnostic
accuracy.False-positivelesionﬁndingsshouldbeasecondary
consideration to the actual sensitivity rate. AFI provides a
simple dichromatic diﬀerence that may help less experienced
endoscopists diagnose neoplastic lesions more easily. For this
reason, we included less experienced endoscopists as well as
highly experienced endoscopists in our study.
In the group of experienced endoscopists, the WLE
sensitivity of 81% was reduced to 70% with AFI although
there was no statistically signiﬁcant diﬀerence indicating that
AFI did not provide an advantage in terms of detection for
that particular group. We postulate that sensitivity using
WLE was already high in the experienced endoscopists
group as variables such as surface irregularity, elasticity,
thickness, hardness, converging folds, and background status
were examined. The ability to interpret those changes using
WLE improves with endoscopic experience. We believe that
experiencedendoscopistsinthisstudyattemptedtointerpret
all characteristics of a lesion using AFI rather than just color
contrast. Reliance on such variables, in fact, can mislead
experienced endoscopists given AFI’s low vision quality.
In contrast, AFI raised detection sensitivity from 65%
to 80% and interobserver variability from 0.29 to 0.52 for
less experienced endoscopists. Although the subtle mucosal
changes of EGC make endoscopic diagnosis a challenge
for less experienced endoscopists using WLE, our ﬁndings
indicated that AFI might facilitate easier diagnosis of neo-
plastic lesions by such endoscopists. This was likely due
to objective evidence of a deﬁnite diﬀerence in coloration
between neoplastic lesions and the surrounding mucosa. AFI
was particularly eﬀective in the diagnosis of ﬂat lesions. The
overall sensitivity and interobserver agreement were unsat-
isfactory, however, for the diﬀerential diagnosis between
neoplastic and benign lesions so we still need to perform a
biopsy.
There are, however, a number of limitations to this pilot
study. Firstly, we used still images taken by experienced
endoscopists, and some of those lesions may not have
been detected at all by less experienced endoscopists during
real-time endoscopy. Quality of the AFI view depends on
technical skill so less experienced endoscopists might not
be able to reproduce the images used in this study. Our
results,therefore,maynotbereﬂectedinactualexamination,
but the results of less experienced endoscopists were in fact
better than experienced endoscopists using the same AFI
pictures. In the future, eﬀectiveness of AFI for screening of
EGC should be assessed in a prospective study including
experienced and less experienced endoscopists with diag-
nosis on a real-time basis. Secondly, in order to make it
simpler, we included only two options “neoplasm exists” or
“no neoplasm” for reviewers. It would have been better to
also have them evaluate lesion characteristics such as AFI
and WLE colors as well as macroscopic type. So we plan to
conduct the real-time evaluations lesion features in the next
study. Thirdly, there was no yardstick used in choosing the
speciﬁc kinds and relative percentages of images presented
in this study, and the percentage of neoplastic lesions was
considerably higher than than that which would normally
be the case in routine gastric screening. The actual choice of
images could have had an eﬀect on the results. For example,
Katoetal.carriedoutaprospectivestudyontheeﬀectiveness
of AFI for detecting EGC [17]. They reported sensitivity of
74% and speciﬁcity of 83% for WLE and sensitivity of 64%
and speciﬁcity of 40% for AFI performed by experienced
endoscopists. Data for the experienced endoscopists in our
study showed a similar results regarding sensitivity of AFI.
Although the high speciﬁcity of 78% with AFI in our study
mayhavebeenaﬀectedbythechoiceofimages,thesensitivity
results in both groups of endoscopists were quite promising.
A number of practical improvements need to be made
before AFI can actually be introduced into a clinical gastric
screening setting (i.e., the AFI system video endoscope
is too large in diameter with poor ﬂexibility and lower
overall image quality), but we believe that AFI has the
potential to increase the sensitivity of endoscopic diagnosis
of neoplastic lesions by less experienced endoscopists. This
would be important not only in Japan but especially in
those countries with a low incidence of gastric cancer.
The AFI system is only being used on a limited basis in
Japan and a few other countries at the present time, and
greater availability and increased usage worldwide of this
systemshoulddemonstrateitseﬀectivenessandleadtowider
acceptance.
The primary advantage of AFI is that it identiﬁes
suspicious lesions as areas evidencing color contrast almost
instantaneously throughout the entire endoscopic ﬁeld. Even
if the false-positive rate using AFI is high, the examining
endoscopists can use other modalities such as chromoen-
doscopy or NBI with magniﬁcation in addition to obtaining
biopsies to verify their initial suspicion of EGC [23, 24].
This is provided, of course, that lesions are detected in the
ﬁrst place. AFI could then become an important technique
for EGC screening by all endoscopists to diagnose suspected
lesions.
This is the ﬁrst study on the eﬀectiveness of AFI
by less experienced endoscopists. Although the results are
encouraging,itshouldbenotedthatthiswasanuncontrolled
pilot trial involving a relatively small number of lesions.
Prospective randomized controlled trials involving a large
number of subjects would be beneﬁcial in the future to more
fullyevaluatetheeﬀectivenessofAFIinthediagnosisofEGC.
In conclusion, the use of AFI in this study increased
sensitivity in the endoscopic diagnosis of gastric neoplasticDiagnostic and Therapeutic Endoscopy 7
lesions by less experienced endoscopists. Such use may
beneﬁcially enhance the clinical impact of EGC screening
by less experienced endoscopists, but this will need to be
conﬁrmed in a prospective study with diagnosis on a real-
time basis.
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